In this episode, you will learn about the role of gadolinium in chronic conditions and about the entity of Gadolinium Deposition Disease.
About My Guest:
My guest for this episode is Dr. Richard Semelka. Richard Semelka, MD has been in practice as a radiologist for 28 years and is a world authority in body MRI, safety in radiology, and gadolinium toxicity. He is a leading published expert in radiology for body MRI and gadolinium toxicity and has made presentations at major meetings all over the world. Dr. Semelka has written over 370 peer-reviewed papers and 16 text-books. He is the first doctor to publish on the entity of Gadolinium Deposition Disease.
Key Takeaways:
What is gadolinium?
What are the symptoms of Gadolinium Deposition Disease?
Are certain populations at higher risk for GDD than others?
Should gadolinium be treated before the immune priming event?
How is gadolinium tested for?
What is the primary route of gadolinium excretion?
Are the symptoms toxigenic or immunogenic?
Does gadolinium cross the blood brain barrier?
Does gadolinium have an effect on the mast cells?
How does gadolinium impact the mitochondria?
Is there a correlation between methylation and response to gadolinium?
Is supporting drainage pathways important?
What are GAD removal and re-equilibration flares?
How is gadolinium chelated from the body?
Can glutathione be helpful in addressing gadolinium toxicity?
The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.
Podden och tillhörande omslagsbild på den här sidan tillhör Scott Forsgren, FDN-P. Innehållet i podden är skapat av Scott Forsgren, FDN-P och inte av, eller tillsammans med, Poddtoppen.
